Illumina Ventures

Illumina Ventures is an independently managed venture capital firm specializing in early-stage investments in genomics and precision health. Founded in 2016 and structured as Illumina Ventures LLC, the firm focuses on life science tools, clinical diagnostics, therapeutics, digital health, and sustainability sectors, including agricultural biotechnology and biomanufacturing.

It maintains a strategic partnership with Illumina, Inc. (NASDAQ: ILMN), the leading provider of DNA sequencing and genomics solutions, which supplies the majority of its capital along with domain expertise. The firm operates Illumina Ventures Labs to accelerate portfolio companies through access to sequencing technology, fully equipped genomics laboratories, mentorship, and additional capital.

Headquartered in Foster City, California, in the San Francisco Bay Area, Illumina Ventures invests primarily across the United States with additional activity in Europe and Asia. It has raised multiple funds under the Illumina Innovation Fund series and maintains a portfolio exceeding 30 active companies, with numerous successful exits including IPOs and acquisitions.

Within the genomics investment ecosystem, Illumina Ventures is positioned as a premier partner for entrepreneurs translating breakthrough science into commercial applications, leveraging deep operating experience and its unique relationship with Illumina to identify and scale transformative companies in precision medicine and related fields.